Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-10-23
2007-10-23
Kaushal, Sumesh (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S093100, C424S093210, C424S450000, C435S320100, C435S325000, C435S455000, C514S04400A
Reexamination Certificate
active
10615292
ABSTRACT:
The present invention relates to a medicament comprising a HGF gene. The medicament of the present invention may be topically applied to the target organs so that the effects can be selectively exhibited, resulting in minimizing the side effects of HGF.
REFERENCES:
patent: 5652225 (1997-07-01), Isner
patent: 5756122 (1998-05-01), Thierry et al.
patent: 6248722 (2001-06-01), Morishita et al.
patent: 6498144 (2002-12-01), Goldberg et al.
patent: 6989374 (2006-01-01), Morishita et al.
patent: 0 461 560 (1991-12-01), None
patent: 0461 560 (1991-12-01), None
patent: 0492614 (1992-07-01), None
patent: 0494369 (1992-07-01), None
patent: WO91 06309 (1991-05-01), None
patent: WO92/05184 (1992-04-01), None
patent: WO93/08821 (1993-05-01), None
patent: WO94/06456 (1994-03-01), None
patent: WO9512681 (1995-05-01), None
patent: WO96/40062 (1996-12-01), None
patent: WO96 40062 (1996-12-01), None
Goncalves et al., Bioessays, 2005, 27: 506-517.
Miller, et al., (1995) FASEB J. 9:190-99.
Taniyama, et al., (2001) Circulation, 104: 2344-50.
Khurana et al., 2001, Hypertension 38:1210-1216.
ML Liu, et al., “Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamine,” Carcinogenesis, Apr. 1995, 16(4): 841-3.
Y. Matsuda, et al., “Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats,” J. Biochem., Sep. 1995, 118(3): 643-9.
G. Shiota, et al., “Inhibitory effect of hepatocyte growth factor on metastasis of hepatocellular carcinoma in transgenic mice,” Res Commun Mol Pathol Pharmacol, Jan. 1996, 91(1): 33-9.
G. Shiota, et al., “Characterization of double transgenic mice expressing hepatocyte growth factor and transforming growth factor alpha,” Res Commun Mol Pathol Pharmacol, Oct. 1995, 90(1): 17-24.
G. Shiota, et al., “Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression,” Hepatology, Apr. 1994, 19(4): 962-72.
G. Shiota, et al., “Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells,” Proc Natl Acad Sci USA, Jan. 1992, 89(1): 373-7.
Eliot M. Rosen et al., “The interaction of HGF-SF with other cytokines in tumor invasion and angiogensis”,Exs, vol. 65, 1993, pp. 301-310.
Eliot M. Rosen et al., Scatter Factor (Hepatocyte Growth Factor) Is A Potent Angiogenesis Factor In Vivo,Symp. Society of Experimental Biology, vol. 47, 1993, pp. 227-234.
Derrick S. Grant et al., Scatter factor induces blood vessel formation in vivo,Proc. Natl. Acad. Sci., vol. 90, Mar. 1993, pp. 1937-1941.
Toshiaki Takebayashi et al., “Hepatocyte Growth Factor/Scatter Factor Modulates Cell Motility, Proliferation and Proteoglycan Synthesis of Chondrocytes”,The Journal of Cell Biology, vol. 129, No. 5, Jun. 1995, pp. 1411-1419.
Naruya Tomita et al., “Direct In Vivo Gene Introduction Into Rat Kidney”,Biochemical and Biophysical Research Communications, vol. 186, No. 1, Jul. 1992, pp. 129-134.
Nakamura et al., “Expression of Local Hepatocyte Growth Factor System in Vascular Tissues”,Biochemic and Biophysical Research Communications, vol. 215, No. 2, 1995, pp. 483-488.
Hayashi et al., “Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth endothelial cells”,Biochemical and Biophysical Research Communications, vol. 220, No. 3, 1996, pp. 539-545.
Nakamura et al., “Molecular Cloning and Expression of Human Hepatocyte Growth Factor”, Nature, vol. 342, Nov. 23, 1989, pp. 440-443, XP000652120.
Miyazawa K. et al., “Molecular Cloning and Sequence Analysis of cDNA for Human Hepatocyte Growth Factor” Biochemical and Biophysical Research Communications, vol. 163, No. 2, Sep. 15, 1989, pp. 967-973, XP000651424.
T. Seki et al., “Isolation and Expression of cDNA for Different Forms of Hepatocyte Growth Factor From Human Leukocyte” Biochemical and Biophysical Research Communications vol. 172, No. 1, Oct. 15, 1990, pp. 321-327, XP002084490.
Supplement to Circulation vol. 96, Abstract No. 3459 (Oct. 21, 1997).
Ueki et al., Nature Medicine 5:226230, 1999.
Ueda, et al., Ann. Thorac. Surg. 67:1726-1731, 1999.
Preprint f article by Taniyama et al., entitled “Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene in Rat and Rabbit Hind Limb Ischemia Models: Pre-clinical Study to Treat Peripheral Arterial Disease.”
Preprint of article by Aoki, et al., entitled “Angiogenesis Induced by Hepatocyte Growth Factor in Non-infarcted Myocardium and Infarcted Myocardium: Up-regulation of Essential Transcription Factor for Angiogenesis, Ets.”
“Scatter Factor (Hepatocyte Growth Factor) is a Potent Angiogenesis Factor In Vitro” by Rosen et al., Society of Experimental Biology, 1993, pp. 227-234.
“Scatter Factor Induces Blood Vessel Formation In Vivo” by Grant, et al., Proc. Nat'l. Acad. Sci USA, vol. 90, Mar. 1993, pp. 1937-1941.
“Hepatocyte Growth Factor/Scatter Factor Modulates Cell Motility, Proliferation, and Proteoglycan Synthesis of Chondrocytes” by Takebayashi et al., Journal of Cell Biology, vol. 29, No. 5 1995, pp. 1411-1419.
“The Interaction of HGF-SF with other Cytokines in Tumor Invasion and Angiogenesis” by Rosen et al., vol. 65, 1993, pp. 301-310.
Biochem and Biophys Res. Comm. 220, 539-545 (1996), Hayashi et al., Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells.
Verma et al., “Gene therapy promises, problems and prospects,” Nature 389:239-242 (1997).
Morishita, et al., “Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells,” Hypertension 21:894-899 (1993).
K. Kato, et al., “Expression of Hepatitis B Virus Surface Antigen in Adult Rat Liver. Co-introduction of DNA and Nuclear Protein by a Simplified Liposome Method”,J. Biol. Chem, Feb. 25, 1991, vol. 266, No. 6, pp. 3361-3364.
F. Bussolino, et al., “Hepatocyte Growth Factor is a Potent Angiogenic Factor which Stimulates Endothelial Cell Motility and Growth”,J. Cell Biol. (1992), vol. 3, pp. 629-641.
Nicholas Miller, et al. “Targeted vectors for gene therapy”The FASEB Journal, vol. 9, Feb. 1995.
Paul D. Robbins, et al., “Viral Vectors for Gene Therapy,”Pharmacol. Ther.,vol. 80, No. 1, pp. 35-47 (1998).
Nicholas Miller, et al., “Targeted vectors for gene therapy,”FASEB, vol. 9, pp. 190-199 (1995).
Yoshiaki Taniyama, et al., “Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene in Rat Diabetic Hind Limb Ischemia Model,”Circulation, vol. 104, pp. 2344-2350 (2001).
Japan Financial News Paper (Dec. 14, 1998 w/English language translation)—www.managinginformation.com.
Local News Section of Japan Financial News Paper (Dec. 14, 1998 w/English language translation)—www.managinginformation.com.
Asahi News Paper (Nov. 2, 1999 w/English language translation)—www.asahi.com.
Meza et al., “Knowledge of perfusion and contractile reserve improves the predictive value of recovery of regional myocardial function postrevascularization”, Circulation, 1997, American Heart Association, Inc., vol. 96, pp. 3459-3465.
Ueki et al., “Hepatocyte growth factor gene therapy of liver cirrhosis in rats”, Nature Medicine, vol. 5, 1999, pp. 226-230.
Ueda et al., “Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart”, Ann Thorac Surg, 1999, The Society of Thoracic Surgeons, vol. 67, pp. 1726-1731.
Taniyama et al., “Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease”, Gene Therapy, 2001, Nature Publishing Group, vol. 8, pp. 1881-189.
Ishikawa et al.,
Morishita Ryuichi
Nakamura Toshikazu
Ochi Takahiro
Ogihara Toshio
Tomita Tetsuya
AnGes MG, Inc.
Hiriyanna Kelaginamane
Kaushal Sumesh
Sughrue Mion Pllc.
LandOfFree
Medicament comprising HGF gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicament comprising HGF gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament comprising HGF gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3876090